Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume $2.09 -0.01 (-0.48%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.12 +0.03 (+1.63%) As of 08/29/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ensysce Biosciences Short Interest DataEnsysce Biosciences (ENSC) has a short interest of 135,800 shares, representing 6.22% of the float (the number of shares available for trading by the public). This marks a -14.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 135,312 shares to cover all short positions.Current Short Interest135,800 sharesPrevious Short Interest159,400 sharesChange Vs. Previous Month-14.81%Dollar Volume Sold Short$283.82 thousandShort Interest Ratio0.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares2,968,000 sharesShort Percent of Float6.22%Today's Trading Volume25,416 sharesAverage Trading Volume135,312 sharesToday's Volume Vs. Average19% Short Selling Ensysce Biosciences? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025135,800 shares $283.82 thousand -14.8%6.2%0.3 $2.09 7/15/2025159,400 shares $336.33 thousand -41.6%N/A0.1 $2.11 6/30/2025272,800 shares $608.34 thousand -7.0%12.5%0.2 $2.23 6/15/2025293,200 shares $606.92 thousand +199.2%13.4%0.2 $2.07 5/31/202598,000 shares $214.62 thousand -71.5%8.1%0.1 $2.19 5/15/2025344,400 shares $737.02 thousand +138.3%28.6%0.2 $2.14 4/30/2025144,500 shares $436.39 thousand +7.1%N/A0.1 $3.02 4/15/2025134,900 shares $302.18 thousand +328.3%11.2%0.1 $2.24 3/31/202531,500 shares $80.64 thousand +43.2%2.6%0.8 $2.56 3/15/202522,000 shares $85.58 thousand -43.3%1.8%0.4 $3.89 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/202538,800 shares $209.13 thousand -1.0%3.2%0.5 $5.39 2/15/202539,200 shares $227.36 thousand +3.7%3.3%0.4 $5.80 1/31/202537,800 shares $259.69 thousand -31.2%N/A0.1 $6.87 1/15/202554,900 shares $393.08 thousand -35.2%N/A0 $7.16 12/31/202484,700 shares $689.46 thousand +85.8%N/A0 $8.14 12/15/202445,600 shares $256.27 thousand -60.5%N/A0 $5.62 11/30/2024115,300 shares $854.37 thousand -97.6%N/A0.1 $7.41 11/15/20244,850,000 shares $3.25 million -23.6%N/A0.2 $0.67 10/31/20246,350,000 shares $3.66 million +5,514.5%43.4%0.2 $0.58 10/15/2024113,100 shares $19.05 thousand -37.2%0.8%0 $0.17 9/30/2024180,200 shares $43.25 thousand -11.4%1.6%0.1 $0.24 9/15/2024203,300 shares $66.28 thousand -70.5%1.9%0.1 $0.33 8/31/2024689,400 shares $272.31 thousand +3,885.0%6.3%0.4 $0.40 8/15/202417,300 shares $6.80 thousand -92.7%0.2%0.2 $0.39 7/31/2024235,500 shares $105.98 thousand +2.5%3.2%1.7 $0.45 7/15/2024229,800 shares $106.05 thousand -16.6%3.2%1.7 $0.46 6/30/2024275,500 shares $139.54 thousand +4.0%3.8%2 $0.51 6/15/2024264,800 shares $137.70 thousand +37.1%3.6%1.8 $0.52 5/31/2024193,200 shares $111.09 thousand +40.0%2.7%1.4 $0.58 5/15/2024138,000 shares $85.44 thousand +1,337.5%1.9%0.9 $0.62 4/30/20249,600 shares $5.68 thousand +134.2%0.1%0 $0.59 4/15/20244,100 shares $2.79 thousand -76.6%0.1%0 $0.68 3/31/202417,500 shares $13.83 thousand -69.0%0.6%0 $0.79 3/15/202456,500 shares $44.84 thousand -34.4%1.9%0 $0.79 2/29/202486,100 shares $80.28 thousand +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54.38 thousand -91.0%2.1%0 $0.89 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 1/15/2024246,300 shares $337.43 thousand +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239.24 thousand +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185.37 thousand +25.3%5.9%0.8 $1.11Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.For the moment, you can watch this interview free of charge – just click here. 11/30/2023133,300 shares $151.96 thousand +96.6%4.8%0.9 $1.14 11/15/202367,800 shares $59.81 thousand +11.3%2.4%0.9 $0.88 10/31/202360,900 shares $56.09 thousand +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33.55 thousand +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29.26 thousand -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46.38 thousand -4.0%1.1%0.1 $1.75 8/31/202327,600 shares $51.06 thousand -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54.99 thousand -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89.65 thousand +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48.22 thousand +24.9%1.4%0 $1.96 6/30/202319,700 shares $36.05 thousand -2.5%2.4%0 $1.83 6/15/202320,200 shares $47.47 thousand +6.3%2.5%0 $2.35 5/31/202319,000 shares $45.03 thousand -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349.89 thousand +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296.25 thousand +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194.37 thousand +5.9%3.9%0.2 $3.99 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351.90 thousand +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96.48 thousand -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167.87 thousand -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367.50 thousand +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55.32 thousand -9.9%1.6%0 $0.77 12/30/202279,700 shares $59.78 thousand -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131.34 thousand -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915.53 thousand +128.9%17.3%0.3 $2.90 11/15/2022137,900 shares $297.86 thousand -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484.50 thousand -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144.63 thousand -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249.40 thousand -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551.84 thousand +134.6%7.4%1 $0.34 8/31/2022681,900 shares $288.03 thousand -5.0%3.3%0.5 $0.42 8/15/2022717,500 shares $350.21 thousand +30.6%3.5%0.6 $0.49 7/31/2022549,200 shares $282.78 thousand -12.1%2.9%0.5 $0.51 7/15/2022624,900 shares $365.63 thousand +20.0%3.3%0.5 $0.59 6/30/2022520,600 shares $452.09 thousand +45.0%2.9%0.4 $0.87 6/15/2022359,100 shares $169.14 thousand +52.9%2.0%0.4 $0.47 5/31/2022234,800 shares $131.65 thousand +94.7%1.5%0.2 $0.56 5/15/2022120,600 shares $81.01 thousand -83.4%0.9%0.1 $0.67 4/30/2022724,300 shares $796.73 thousand +65.0%7.6%0.9 $1.10 4/15/2022439,000 shares $469.73 thousand +41.5%4.6%0.6 $1.07 3/31/2022310,200 shares $353.63 thousand +139.7%4.0%0.3 $1.14 3/15/2022129,400 shares $139.75 thousand -64.0%1.7%0.1 $1.08 2/28/2022359,300 shares $402.42 thousand +154.5%4.7%0.1 $1.12 2/15/2022141,200 shares $211.80 thousand -59.6%1.8%0 $1.50 1/31/2022349,700 shares $608.48 thousand +229.9%4.5%0 $1.74 1/15/2022106,000 shares $347.68 thousand -86.8%N/A0 $3.28 12/31/2021801,600 shares $3.77 million -7.7%10.4%0.1 $4.70 12/15/2021868,100 shares $3.57 million +702.3%11.2%0.1 $4.11 11/30/2021108,200 shares $170.96 thousand +18.1%1.4%0 $1.58 11/15/202191,600 shares $196.02 thousand -58.3%1.2%0.1 $2.14Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.For the moment, you can watch this interview free of charge – just click here. 10/29/2021219,900 shares $483.78 thousand +140.3%2.8%0.2 $2.20 10/15/202191,500 shares $216.86 thousand -38.8%1.2%0 $2.37 9/30/2021149,400 shares $452.68 thousand +280.2%1.6%0.1 $3.03 9/15/202139,300 shares $120.65 thousand -20.1%0.4%0 $3.07 8/31/202149,200 shares $155.47 thousand +59.7%0.5%0 $3.16 8/13/202130,800 shares $101.02 thousand No Change0.3%0 $3.28 ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 135,800 shares of ENSC short. 6.22% of Ensysce Biosciences' shares are currently sold short. Learn More on Ensysce Biosciences' current short interest. What is a good short interest percentage for Ensysce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.22% of Ensysce Biosciences' floating shares are currently sold short. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 135,800 shares, a decline of 14.8% from the previous total of 159,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ensysce Biosciences' short interest compare to its competitors? 6.22% of Ensysce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ensysce Biosciences: Q32 Bio Inc. (9.28%), Passage Bio, Inc. (3.21%), NanoViricides, Inc. (0.57%), Sonnet BioTherapeutics Holdings, Inc. (18.04%), Citius Pharmaceuticals, Inc. (7.31%), Cingulate Inc. (4.54%), Lisata Therapeutics, Inc. (0.70%), Tharimmune, Inc. (0.29%), BioAtla, Inc. (7.56%), Relmada Therapeutics, Inc. (1.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Q32 Bio Short Interest Passage Bio Short Interest NanoViricides Short Interest Sonnet BioTherapeutics Short Interest Citius Pharmaceuticals Short Interest Cingulate Short Interest Lisata Therapeutics Short Interest Tharimmune Short Interest BioAtla Short Interest Relmada Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
